Drugs / Hypertonic saline
last change Jan 2026 re-read 9 days ago

Hypertonic saline

Developed for
cystic fibrosis · acute bronchiolitis · bronchiolitis · traumatic brain injury · brain edema · bronchiectasis · intracranial hypertension · pulmonary non-tuberculous mycobacterial infection
+28 more · respiratory failure · acute lung injury · acute respiratory distress syndrome · cerebral malaria · chronic obstructive pulmonary disease · chronic pain syndrome · chronic rhinosinusitis · corneal edema · COVID-19 · female stress incontinence · hidradenitis suppurativa · infectious disease with sepsis · intracranial hypotension · intracranial vasospasm · nephrotic syndrome · preeclampsia · primary ciliary dyskinesia · pulmonary edema · radiculopathy · rotator cuff syndrome · stroke disorder · subarachnoid hemorrhage · traumatic encephalopathy · urethral syndrome · acute liver failure · asthma · lung disorder · rectal prolapse
Investigated by
Cystic Fibrosis Foundation · National Heart, Lung, and Blood Institute (NHLBI) · Assiut University · Aalborg University · CF Therapeutics Development Network Coordinating Center · National Institute of Neurological Disorders and Stroke (NINDS)
+80 more · Northwestern University · Parion Sciences · The Hospital for Sick Children · Thomas Jefferson University · University of Colorado, Denver · University of Washington · University of Washington, the Collaborative Health Studies Coordinating Center · Aga Khan University · Ann & Robert H Lurie Children's Hospital of Chicago · Assistance Publique - Hôpitaux de Paris · Belfast Health and Social Care Trust · Beth Israel Deaconess Medical Center · Canadian Cystic Fibrosis Foundation · Canadian Department of National Defence · Canadian Institutes of Health Research (CIHR) · Central Directorate of the Army Health Service · Chiesi España · Children's Hospital of Philadelphia · Children's National Research Institute · Cystic Fibrosis Trust · Defence Research and Development Canada · Denver Health and Hospital Authority · EPC Education s.r.o. · East Slovak Institute for Cardiovascular Diseases · German Center for Lung Research · Hamad Medical Corporation · Haukeland University Hospital · Heart and Stroke Foundation of Canada · Heidelberg University · Hospital General Naval de Alta Especialidad - Escuela Medico Naval · Hospital General de Ciudad Real · Hospital General de Niños Pedro de Elizalde · Hospital San Carlos, Madrid · Inonu University · Johns Hopkins University · Joseph Zabner · Kamuzu University of Health Sciences · Le Bonheur Children's Hospital · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Massachusetts General Hospital · Mayo Clinic · Medical University of Bialystok · Michigan State University · Muhammad Aamir Latif · NTM Info & Research, Inc. · National Health and Medical Research Council, Australia · National Institute of Allergy and Infectious Diseases (NIAID) · National Science and Technology Council, Taiwan · Nationwide Children's Hospital · Nazmy Edward Seif · New York University · Ohio State University · OhioHealth · Oregon Health and Science University · Otsuka America Pharmaceutical · Philips Respironics · Queen's University, Belfast · Rady Children's Hospital, San Diego · Rothman Institute Orthopaedics · Royal Prince Alfred Hospital, Sydney, Australia · Sheikh Khalifa Medical City · Slovak Academy of Sciences · Taipei Veterans General Hospital, Taiwan · Tanta University · The Danish Rheumatism Association · The Institute of Circulatory and Respiratory Health (ICRH) · Tim Corcoran · Turgut Ozal University · U.S. Army Medical Research and Development Command · University Health Network, Toronto · University Hospital, Grenoble · University Hospitals Cleveland Medical Center · University of California, San Diego · University of Castilla-La Mancha · all 86 on the full record

Trials 60

200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 17 trials
Phase 1 NCT02947126 Jan 2017 → Feb 2020 cystic fibrosis Tim Corcoran Completed No outcome recorded
Phase 1 NCT02141191 Jun 2014 → Oct 2015 cystic fibrosis University of Pittsburgh Completed No outcome recorded
Phase 1 NCT01713595 Oct 2013 → May 2015 pulmonary edema Mayo Clinic Withdrawn No outcome recorded
Phase 1 NCT01667666 May 2012 → Nov 2018 acute lung injury, adult acute respiratory distress syndrome Denver Health and Hospital Authority Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT00753987 Mar → Jul 2006 cystic fibrosis The Hospital for Sick Children Completed No outcome recorded
Phase 1 NCT00181077 Jun 2003 → Apr 2006 preeclampsia Johns Hopkins University Completed No outcome recorded
Phase 1 NCT00359697 — intracranial hypertension Thomas Jefferson University Unknown No outcome recorded
Phase 1/26 trials
Phase 1/2 NCT06370975 Aug 2024 → Aug 2025 — Assiut University Unknown No outcome recorded
Phase 1/2 NCT02432157 Jan 2015 → Jan 2017 intracranial vasospasm, subarachnoid hemorrhage Thomas Jefferson University Unknown No outcome recorded
Phase 1/2 NCT01945944 Oct 2013 → Apr 2014 respiratory failure University Hospitals Cleveland Medical Center Completed No outcome recorded
Phase 1/2 NCT01605357 Jul 2012 → Jul 2013 brain edema, traumatic brain injury Massachusetts General Hospital Withdrawn No outcome recorded
Phase 1/2 NCT01355796 May 2011 → Feb 2015 cystic fibrosis Joseph Zabner Completed No outcome recorded
Phase 1/2 NCT01612494 Mar 2010 → Apr 2012 — University of California, San Diego Completed No outcome recorded
Phase 24 trials · 1 met primary
Phase 2 NCT03276494 Apr 2017 → Apr 2018 brain edema, intracranial hypotension, stroke disorder Ohio State University Completed No outcome recorded
Phase 2 NCT02871778 Aug 2016 → Nov 2018 primary ciliary dyskinesia Parion Sciences Completed Met primary
Phase 2 NCT02805595 Aug 2016 → Nov 2022 hidradenitis suppurativa Beth Israel Deaconess Medical Center Completed No outcome recorded
Phase 2 NCT01619657 Jun 2012 → Nov 2016 cystic fibrosis Heidelberg University Completed No outcome recorded
Phase 2/32 trials · 1 met primary
Phase 2/3 NCT02950883 Mar 2015 → Dec 2020 cystic fibrosis University of Washington, the Collaborative Health Studies Coordinating Center Completed Met primary
Phase 2/3 NCT00151905 Nov 2003 → Sep 2006 bronchiolitis Sheikh Khalifa Medical City Completed No outcome recorded
Phase 311 trials · 1 met primary · 4 missed
Phase 3 NCT04140214 Jun 2018 → Sep 2024 bronchiectasis Belfast Health and Social Care Trust Completed No outcome recorded
Phase 3 NCT03300648 Jan 2018 → Dec 2023 cerebral malaria Michigan State University Completed No outcome recorded
Phase 3 NCT02782520 Aug 2016 → Oct 2017 — University Hospital, Grenoble Completed No outcome recorded
Phase 3 NCT04812574 Jan 2014 → Apr 2018 female stress incontinence Turgut Ozal University Completed No outcome recorded
Phase 3 NCT01777347 Oct 2012 → Apr 2014 acute bronchiolitis Assistance Publique - Hôpitaux de Paris Completed Missed primary
Phase 3 NCT01271114 Jun 2012 → Dec 2013 infectious disease with sepsis Hospital General de Ciudad Real Terminated No outcome recorded Stop: Enrollment
Phase 3 NCT01028339 Jul 2008 → Jun 2012 traumatic brain injury Central Directorate of the Army Health Service Terminated No outcome recorded Stop: Enrollment
Phase 3 NCT00635141 Mar → Dec 2008 cystic fibrosis The Hospital for Sick Children Completed Met primary
Phase 3 NCT00316004 May 2006 → May 2009 traumatic brain injury University of Washington Terminated Missed primary
Phase 3 NCT00316017 May 2006 → Aug 2009 — University of Washington Terminated Missed primary
Phase 412 trials · 1 met primary · 3 missed
Phase 4 NCT04921943 May 2021 → Dec 2025 overdue pulmonary non-tuberculous mycobacterial infection Oregon Health and Science University Recruiting No outcome recorded
Phase 4 NCT03880903 Jul 2020 → Mar 2021 acute bronchiolitis Assiut University Unknown No outcome recorded
Phase 4 NCT03738735 Jan 2019 → Jan 2020 rotator cuff syndrome Rothman Institute Orthopaedics Unknown No outcome recorded
Phase 4 NCT03324477 Nov 2017 → Dec 2023 urethral syndrome Nazmy Edward Seif Completed No outcome recorded
Phase 4 NCT02266875 Oct 2014 → Jan 2017 chronic obstructive pulmonary disease OhioHealth Completed Missed primary
Phase 4 NCT01973140 Nov 2013 → Dec 2015 — Northwestern University Completed No outcome recorded
Phase 4 NCT01834820 Jan 2013 → Jun 2015 bronchiolitis Hospital General Naval de Alta Especialidad - Escuela Medico Naval Completed No outcome recorded
Phase 4 NCT01745081 Sep 2012 → Sep 2014 intracranial hypertension University of Sherbrooke Unknown No outcome recorded
Phase 4 NCT01871857 Nov 2010 → Aug 2012 acute bronchiolitis Le Bonheur Children's Hospital Completed Missed primary
Phase 4 NCT01247064 Oct 2010 → Dec 2011 bronchiolitis Children's Hospital of Philadelphia Completed Missed primary
Phase not applicable18 trials · 1 met primary · 1 missed
— NCT07647575 Oct 2025 → Apr 2028 expected bronchiectasis, pulmonary non-tuberculous mycobacterial infection Taipei Veterans General Hospital, Taiwan Recruiting No outcome recorded
— NCT07605273 Jun → Dec 2025 corneal edema Muhammad Aamir Latif Completed No outcome recorded
— NCT06226402 Sep 2023 → Sep 2024 acute respiratory distress syndrome Tanta University Unknown No outcome recorded
— NCT04787198 Oct 2022 → Dec 2024 — Aalborg University Unknown No outcome recorded
— NCT04341688 Dec 2021 → Jun 2022 COVID-19 Aga Khan University Unknown No outcome recorded
— NCT07411950 Jan 2021 → May 2025 chronic pain syndrome, radiculopathy EPC Education s.r.o. Completed No outcome recorded
— NCT03750136 Dec 2018 → Jan 2023 nephrotic syndrome Medical University of Bialystok Unknown No outcome recorded
— NCT03940118 Jun 2018 → Apr 2019 tracheal disorder Hospital San Carlos, Madrid Completed No outcome recorded
— NCT03174483 Jun 2017 → Jun 2018 chronic rhinosinusitis Assiut University Unknown No outcome recorded
— NCT04001218 Apr → Sep 2015 — Aalborg University Completed No outcome recorded
Comparator or background therapy29 trials
Phase 0 NCT06174584 Comparator Feb 2021 → Jan 2022 rectal prolapse Shaheed Zulfiqar Ali Bhutto Medical University Completed No outcome recorded
Phase 0 NCT04686344 Comparator Dec 2020 → Aug 2021 optic nerve disorder Cairo University Completed No outcome recorded
Phase 1 NCT01223183 Comparator Sep 2010 → Dec 2012 cystic fibrosis University of Pittsburgh Completed No outcome recorded
Phase 1/2 NCT00928135 Comparator Jan 2013 → Apr 2018 cystic fibrosis Joseph Zabner Completed No outcome recorded
Phase 2 NCT04671407 Comparator Jan 2021 → Dec 2022 — Kaplan Medical Center Unknown No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2017-10-25 Vertex Pharmaceuticals Incorporated Results Vertex Reports Third-Quarter 2017 Financial Results vrtx.com ↗
In patients being treated with ORKAMBI, the addition of hypertonic saline resulted in a decrease in ppFEV1 of 0.1 percentage points at Day 28.

All press releases naming this drug 1 release

DateIssuerRelease

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 90 sources stand behind the page.

FieldValueCited text
Known as hypertonic saline “Hypertonic saline: Nebulized hypertonic saline has been suggested as a potential therapy for ARDS patients due to its ability to reduce airway inflammation and improve...” NCT07286409 ↗
88

“Nebulized hypertonic saline (HS) has been shown to increase mucociliary clearance in the airways of individuals with healthy lungs.” NCT01247064 ↗

“After the head fixation 3 mL.kg-1 %3 hypertonic saline will be administered over the 20 min intravenously.” NCT04314674 ↗

“The two hypertonic solutions most commonly used are Mannitol 20% and Hypertonic Saline 7.5%.” NCT00199511 ↗

“Periurethral hypertonic saline (10% NaCl) injection” NCT04812574 ↗

“2% hypertonic saline (Plabottle® by Otsuka Inc.)” PMID 32928313 ↗ Sep 2020

“nebulized hypertonic saline (HS) treatment” PMID 28586918 ↗ Aug 2017

“Hypertonic saline (HTS) is a compound” NCT02432157 ↗

“hypertonic saline (10 mL)” NCT07411950 ↗

“Drug: Hypertonic saline” NCT01355796 ↗

NCT04787198 ↗

Show 78 more sources

Known as ClNa 3% (sodium chloride 3%) “ClNa 3% (sodium chloride 3%)” NCT01238848 ↗
Known as HTS “There has been substantial retrospective data and limited prospective data in children which suggests that hypertonic saline (HTS) can improve the control of intracranial...” NCT00142090 ↗
2

“Inhalation of hypertonic saline (HTS) has short term positive effects on airways clearance in non-cystic fibrosis (CF) bronchiectasis, however its long term effects are unknown.” PMID 22349069 ↗ Feb 2012

“Hypertonic saline (HTS) is a compound” NCT02432157 ↗

Known as Hyper-Sal, inhaled saline “Hyper-Sal™, inhaled saline” NCT02378467 ↗
Known as hyperosmolar saline “Hyperosmolar saline is an irrigation solution with a higher concentration of solutes that will be used intraoperatively to washout the surgical field.” NCT03738735 ↗
Known as Hypertonic Saline Solution “Sodium Lactate Versus Hypertonic Saline Solution in the Treatment of Intracranial Hypertensive Episodes in Severe Brain Injured Patients” NCT06110429 ↗
Known as Plabottle “2% hypertonic saline (Plabottle® by Otsuka Inc.)” PMID 32928313 ↗ Sep 2020
Action Inhibit “exerts inhibitory effects in several stages of the inflammatory cascade” NCT06226402 ↗
Route Intravenous “3% hypertonic saline (salt-water solution) given in a vein” NCT00142090 ↗